Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare
Lexaria Bioscience Corp. Shareholder Equity 2016–2025
Lexaria Bioscience Corp. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lexaria Bioscience Corp. shareholder equity as of August 31, 2025: 3.0M, a 62.80% decrease year-over-year.
- Lexaria Bioscience Corp. shareholder equity for 2025 were 3.0M, a 62.80% decrease from 2024.
- Lexaria Bioscience Corp. shareholder equity for 2024 were 8.0M, a 164.00% increase from 2023.
- Lexaria Bioscience Corp. shareholder equity for 2023 were 3.0M, a 61.70% decrease from 2022.
- Lexaria Bioscience Corp. shareholder equity for 2022 were 7.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lexaria Bioscience Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $8 |
| 2023 | $3 |
| 2022 | $8 |
| 2021 | $13 |
| 2020 | $2 |
| 2019 | $2 |
| 2018 | $2 |
| 2017 | $3 |
| 2016 | $0 |
Lexaria Bioscience Corp. Shareholder Equity — FAQ
Lexaria Bioscience Corp. (LEXX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LEXX's shareholder equity history?
The chart and table above show Lexaria Bioscience Corp.'s shareholder equity by year and by quarter, including the growth rate.